SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · IEX Real-Time Price · USD
2.860
-0.180 (-5.92%)
At close: Jul 2, 2024, 4:00 PM
3.000
+0.140 (4.90%)
After-hours: Jul 2, 2024, 6:32 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $26.40 million as of July 2, 2024. Its market cap has decreased by -35.30% in one year.
Market Cap
26.40M
Enterprise Value
-12.21M
1-Year Change
-35.30%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since January 12, 2021, SAB Biotherapeutics's market cap has decreased from $134.00M to $26.40M, a decrease of -80.30%. That is a compound annual growth rate of -37.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 28.10M | -21.94% |
| Dec 29, 2023 | 36.00M | 41.73% |
| Dec 30, 2022 | 25.40M | -92.52% |
| Dec 31, 2021 | 339.50M | 153.36% |
| Jan 12, 2021 | 134.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beyond Air | 29.20M |
| Rapid Micro Biosystems | 29.15M |
| SeaStar Medical Holding | 29.04M |
| Enlivex Therapeutics | 28.80M |
| Movano | 28.59M |
| Bolt Biotherapeutics | 27.91M |
| VYNE Therapeutics | 27.89M |
| Aligos Therapeutics | 27.68M |